Phase 4
Completed N=12
Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
Source: ClinicalTrials.gov NCT04135937 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcomePrimary: Number of Participants Who Participate in the Post-treatment Interview — 9 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Smoking is a significant cause of damage to health and quality of life specifically for Veterans with human immunodeficiency virus (HIV). Smoking cessation interventions for this population are lacking. The primary aim of this project is to explore smoking cessation treatment preferences among Veteran smokers living with HIV. The study team will refine the design and content of a smoking cessation treatment for Veteran smokers living with HIV. The intervention uses mobile health and telehealth technology to personalize smoking cessation counseling and medications and provide relapse prevention text messaging.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Participate in the Post-treatment Interview |
9 | — |
Eligibility Criteria
Inclusion Criteria
- VHA patient
- HIV positive serostatus
- currently smoking 7 cigarettes per week
- willing to complete study procedures. Exclusion criteria are:
Exclusion Criteria
- current hospitalization
- acute risk for suicide documented in the medical record
- inability to complete study procedures.
Data sourced from ClinicalTrials.gov (NCT04135937). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.